Version 1
: Received: 21 January 2023 / Approved: 26 January 2023 / Online: 26 January 2023 (02:50:29 CET)
How to cite:
Giannotta, G.; Murrone, A.; Giannotta, N. COVID-19 mRNA Vaccines: From Inflammation to Hyperinflammation. Preprints2023, 2023010460. https://doi.org/10.20944/preprints202301.0460.v1.
Giannotta, G.; Murrone, A.; Giannotta, N. COVID-19 mRNA Vaccines: From Inflammation to Hyperinflammation. Preprints 2023, 2023010460. https://doi.org/10.20944/preprints202301.0460.v1.
Cite as:
Giannotta, G.; Murrone, A.; Giannotta, N. COVID-19 mRNA Vaccines: From Inflammation to Hyperinflammation. Preprints2023, 2023010460. https://doi.org/10.20944/preprints202301.0460.v1.
Giannotta, G.; Murrone, A.; Giannotta, N. COVID-19 mRNA Vaccines: From Inflammation to Hyperinflammation. Preprints 2023, 2023010460. https://doi.org/10.20944/preprints202301.0460.v1.
Abstract
Each injection of any known vaccine results in a strong expression of pro-inflammatory cytokines. This is the result of the innate immune system activation, without which no adaptive response to the injection of vaccines is possible. COVID-19 mRNA vaccines would not escape this rule. Unfortunately, the degree of inflammation produced by these vaccines is variable, probably depending on the genetic background and previous immune experiences, which through epigenetic modifications, could have made the innate immune system of each individual tolerant or reactive to subsequent immune stimulations.We hypothesize that we can move from a limited pro-inflammatory condition to conditions of increasing expression of pro-inflammatory cytokines that can culminate in multisystem hyperinflammatory syndromes following COVID-19 mRNA vaccines (MIS-V). We have graphically represented this idea in a hypothetical inflammatory pyramid (IP) and we have correlated the time factor to the degree of inflammation produced after the injection of vaccines. Furthermore, we have placed the clinical manifestations within this hypothetical IP, correlating them to the degree of inflammation produced. Surprisingly, excluding the possible presence of an early MIS-V, the time factor and the complexity of clinical manifestations are correlated to the increasing degree of inflammation: symptoms, heart disease and syndromes (MIS-V).
Keywords
COVID-19 mRNA vaccines; Myo-pericarditis and COVID-19 mRNA vaccines; Multisystem-Inflammatory-Syndrome and COVID-19 mRNA vaccines; arrhythmias and COVID-19 mRNA vaccines; Pathogenesis of myocarditis following COVID-19 mRNA vaccines; MIS-A; MIS-C; MIS-V; Myocarditis; COVID-19 mRNA vaccine Adverse Events.
Subject
MEDICINE & PHARMACOLOGY, Cardiology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.